Regenerative Pharmacology for Diabetes Mellitus

Mark E. Furth, PhD, is Technology Development Officer at the Wake Forest Institute for Regenerative Medicine. He received his doctoral degree in Molecular Biology from the University of Wisconsin-Madison for work on control elements for DNA replication, and did postdoctoral research in stem cell biology and oncogenes at the MRC Laboratory of Molecular Biology, Cambridge, UK, and the National Cancer Institute, Bethesda, MD. He headed the Laboratory of Molecular Oncogenesis at the Memorial Sloan-Kettering Cancer Center, and then spent eighteen years in executive research positions in the biotechnology and pharmaceutical industries. His current research focuses on medical applications of stem cells.